Chris Marlett
Directeur Général chez MDB CAPITAL HOLDINGS, LLC
Fortune : 35 M $ au 30/04/2024
Profil
Christopher Anthony Marlett is the founder of PatentVest, Inc. (founded in 2003), Public Ventures LLC (founded in 1997), and MDB Capital Holdings LLC (founded in 1997).
He is currently a Director at Invizyne Technologies, Inc. (since 2019).
He has also held positions as a Director at Orion Acquisition Corp.
II, The Arena Group Holdings, Inc., and Cue Biopharma, Inc. Mr. Marlett obtained his undergraduate degree from the University of Southern California in 1986.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MDB CAPITAL HOLDINGS LLC
75,10% | 29/03/2024 | 3 755 000 ( 75,10% ) | 34 M $ | 30/04/2024 |
| 29/03/2024 | 79 933 ( 1,86% ) | 719 397 $ | 30/04/2024 | |
HEARTBEAM, INC.
0,01% | 20/08/2023 | 3 911 ( 0,01% ) | 7 689 $ | 30/04/2024 |
Postes actifs de Chris Marlett
| Sociétés | Poste | Début |
|---|---|---|
| MDB CAPITAL HOLDINGS, LLC | Directeur Général | 01/01/1997 |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Directeur Général | 01/01/1997 |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Directeur/Membre du Conseil | 01/04/2019 |
Anciens postes connus de Chris Marlett
| Sociétés | Poste | Fin |
|---|---|---|
| CUE BIOPHARMA, INC. | Directeur/Membre du Conseil | 09/02/2020 |
| THE ARENA GROUP HOLDINGS, INC. | Directeur Général | 04/11/2016 |
| Orion Acquisition Corp. II | Directeur/Membre du Conseil | 20/05/2005 |
| PatentVest, Inc. | Fondateur | - |
Formation de Chris Marlett
| University of Southern California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| THE ARENA GROUP HOLDINGS, INC. | Technology Services |
| CUE BIOPHARMA, INC. | Health Technology |
| MDB CAPITAL HOLDINGS, LLC | Finance |
| Entreprise privées | 4 |
|---|---|
| Orion Acquisition Corp. II | Finance |
Public Ventures LLC
Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | Finance |
| PatentVest, Inc. | |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |